A. S. Williams

575 total citations
25 papers, 453 citations indexed

About

A. S. Williams is a scholar working on Pulmonary and Respiratory Medicine, Plant Science and Surgery. According to data from OpenAlex, A. S. Williams has authored 25 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Plant Science and 4 papers in Surgery. Recurrent topics in A. S. Williams's work include Ovarian cancer diagnosis and treatment (4 papers), Nematode management and characterization studies (3 papers) and Prostate Cancer Treatment and Research (3 papers). A. S. Williams is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Nematode management and characterization studies (3 papers) and Prostate Cancer Treatment and Research (3 papers). A. S. Williams collaborates with scholars based in United States and United Kingdom. A. S. Williams's co-authors include John Nemunaitis, Casey Cunningham, Stephen C. Olson, William R. Grove, L. Pauer, Alan J. Kraker, Mary E. Rumpho, Cesar V. Mujer, Robert Kennedy and Ralph Zinner and has published in prestigious journals such as Journal of Clinical Oncology, PLANT PHYSIOLOGY and Clinical Cancer Research.

In The Last Decade

A. S. Williams

24 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. S. Williams United States 9 241 140 102 54 46 25 453
Shigekazu Nakatsugawa Japan 13 227 0.9× 81 0.6× 70 0.7× 21 0.4× 83 1.8× 28 439
Petra Laspe Germany 14 325 1.3× 104 0.7× 43 0.4× 15 0.3× 109 2.4× 19 564
Zhi-Ren Liu United States 9 516 2.1× 159 1.1× 57 0.6× 15 0.3× 96 2.1× 9 641
Marie‐Pier Thibault Canada 10 177 0.7× 107 0.8× 53 0.5× 16 0.3× 35 0.8× 17 437
Yongqing Gu China 15 357 1.5× 132 0.9× 140 1.4× 25 0.5× 125 2.7× 35 565
Mary G. West United States 7 461 1.9× 120 0.9× 32 0.3× 27 0.5× 150 3.3× 10 531
De-Chang Wu China 9 455 1.9× 170 1.2× 28 0.3× 18 0.3× 103 2.2× 21 568
Dubravka Donjerković United States 7 292 1.2× 130 0.9× 24 0.2× 14 0.3× 64 1.4× 10 467
Aiko Kinomura Japan 13 528 2.2× 128 0.9× 38 0.4× 50 0.9× 143 3.1× 22 621
Frauke Goeman Italy 18 407 1.7× 161 1.1× 56 0.5× 22 0.4× 186 4.0× 32 625

Countries citing papers authored by A. S. Williams

Since Specialization
Citations

This map shows the geographic impact of A. S. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. S. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. S. Williams more than expected).

Fields of papers citing papers by A. S. Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. S. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. S. Williams. The network helps show where A. S. Williams may publish in the future.

Co-authorship network of co-authors of A. S. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of A. S. Williams. A scholar is included among the top collaborators of A. S. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. S. Williams. A. S. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGovern, Emily, et al.. (2025). The role of income and rurality in US cancer mortality: A SEER analysis.. Journal of Clinical Oncology. 43(16_suppl).
2.
Bell, Ronny A., Anna Bellatorre, Jasmin Divers, et al.. (2022). OR28-2 Assessing Longitudinal Disparities in Insulin Pump Use Among Youth with Type 1 Diabetes. Journal of the Endocrine Society. 6(Supplement_1). A354–A355. 1 indexed citations
3.
4.
Thiel, David D., et al.. (2012). Impact of Fellowship Training on One-Year Outcomes of Robotic-Assisted Prostatectomy. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 16(2). 195–201. 7 indexed citations
5.
Thiel, David D., Christine M. Lohse, A. S. Williams, et al.. (2012). Kidney Size and Cancer-specific Survival for Patients Undergoing Nephrectomy for pT1 Clear Cell Renal Cell Carcinoma. Urology. 80(1). 147–150. 5 indexed citations
6.
Thiel, David D., Christine M. Lohse, A. S. Williams, et al.. (2012). Three‐dimensional tumour volume and cancer‐specific survival for patients undergoing nephrectomy to treat pT1 clear‐cell renal cell carcinoma. British Journal of Urology. 110(7). 956–960. 26 indexed citations
7.
Michie, Caroline O., Dana Faratian, Tzyvia Rye, et al.. (2011). Multimodality evaluation of excision repair cross-complementation 1 (ERCC1) expression as a predictive biomarker for platinum resistance in epithelial ovarian cancer (EOC).. Journal of Clinical Oncology. 29(15_suppl). 5055–5055. 1 indexed citations
8.
Goldkorn, Amir, Tao Xu, Binfeng Lu, et al.. (2010). Circulating tumor cell capture and analysis in a multicenter SWOG-coordinated prostate cancer trial.. Journal of Clinical Oncology. 28(15_suppl). TPS342–TPS342. 1 indexed citations
9.
Gourley, Charlie, J F Smyth, Melanie Mackean, et al.. (2006). Phase II study of letrozole in estrogen receptor (ER) positive relapsed epithelial ovarian cancer (EOC). Journal of Clinical Oncology. 24(18_suppl). 5025–5025. 12 indexed citations
10.
Nemunaitis, John, Irene Eiseman, Casey Cunningham, et al.. (2005). Phase 1 Clinical and Pharmacokinetics Evaluation of Oral CI-1033 in Patients with Refractory Cancer. Clinical Cancer Research. 11(10). 3846–3853. 71 indexed citations
11.
Pauer, L., Casey Cunningham, A. S. Williams, et al.. (2004). Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors. Cancer Investigation. 22(6). 886–896. 94 indexed citations
12.
Nemunaitis, John, Douglas Orr, Casey Cunningham, et al.. (2003). Phase I Study of Oral CI-994 in Combination with Gemcitabine in Treatment of Patients with Advanced Cancer. The Cancer Journal. 9(1). 58–66. 49 indexed citations
13.
Stewart, Mark J., Lucinda G. Carr, Trent R. Stewart, et al.. (1999). An A/G Polymorphism in the Promoter of Mitochondrial Aldehyde Dehydrogenase (ALDH2): Effects of the Sequence Variant on Transcription Factor Binding and Promoter Strength. Alcoholism Clinical and Experimental Research. 23(6). 963–968. 43 indexed citations
14.
Eccles, Diana, et al.. (1997). Segregation analysis of ovarian cancer using diathesis to include other cancers. Annals of Human Genetics. 61(3). 243–252. 2 indexed citations
15.
Mujer, Cesar V., et al.. (1995). Identification and Gene Expression of Anaerobically Induced Enolase in Echinochloa phyllopogon and Echinochloa crus-pavonis. PLANT PHYSIOLOGY. 109(2). 433–443. 29 indexed citations
16.
17.
Williams, A. S., et al.. (1975). Wheat spindle streak mosaic virus in Kentucky.. ˜The œPlant disease reporter. 59(11). 888–889. 6 indexed citations
18.
Williams, A. S., et al.. (1971). Population Behavior of Meloidogyne graminis in Field-grown 'Tifgreen' Bermudagrass.. PubMed. 3(4). 386–9. 4 indexed citations
19.
Williams, A. S., et al.. (1969). The Influence of Temperature on Development and Sex Differentiation of Meloidogyne graminis.. PubMed. 1(3). 212–5. 3 indexed citations
20.
Williams, A. S., et al.. (1968). Occurrence of Hypsoperine graminis in Virginia and additions to the host range.. ˜The œPlant disease reporter. 52(2). 162–163. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigekazu Nakatsugawa Breakdown of academic impact, for papers by Petra Laspe Breakdown of academic impact, for papers by Zhi-Ren Liu Breakdown of academic impact, for papers by Marie‐Pier Thibault Breakdown of academic impact, for papers by Yongqing Gu Breakdown of academic impact, for papers by Mary G. West Breakdown of academic impact, for papers by De-Chang Wu Breakdown of academic impact, for papers by Dubravka Donjerković Breakdown of academic impact, for papers by Aiko Kinomura Breakdown of academic impact, for papers by Frauke Goeman
Rankless by CCL
2026